| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8743777 | Transplant Immunology | 2018 | 31 Pages |
Abstract
Sirt1 might be involved in the pathogenic process of IF and inflammation at the early stage of CRAD. Thus, Sirt1 represents a novel therapeutic strategy and target for the early prevention and treatment of CRAD.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Yue Xia, Jin Deng, Qin Zhou, Xiaofei Shao, Xingyan Yang, Mengjiao Sha, Hequn Zou,